Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease
Authors
Keywords
-
Journal
Arab Journal of Gastroenterology
Volume 24, Issue 1, Pages 29-33
Publisher
Elsevier BV
Online
2023-02-21
DOI
10.1016/j.ajg.2022.10.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular Disease in Chronic Kidney Disease
- (2021) Joachim Jankowski et al. CIRCULATION
- An update on direct antiviral agents for the treatment of hepatitis C
- (2021) Carol Stanciu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Epidemiology of hepatitis C virus infection
- (2021) Françoise Roudot-Thoraval Clinics and Research in Hepatology and Gastroenterology
- Screening and Treatment Program to Eliminate Hepatitis C in Egypt
- (2020) Imam Waked et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care
- (2020) Seong Hee Kang et al. Clinical and Molecular Hepatology
- Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study
- (2018) A. A. Butt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort
- (2018) Jan Sperl et al. KIDNEY & BLOOD PRESSURE RESEARCH
- High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease
- (2018) Faisal M. Sanai et al. LIVER INTERNATIONAL
- Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease
- (2018) Mohamed A. Mekky et al. Clinics and Research in Hepatology and Gastroenterology
- Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
- (2017) Edward Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
- (2016) Paul J. Pockros et al. GASTROENTEROLOGY
- Finally, safe and effective treatment options for hepatitis C in hemodialysis patients
- (2016) Kalyan Ram Bhamidimarri et al. JOURNAL OF HEPATOLOGY
- Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks
- (2016) Jordan J. Feld et al. JOURNAL OF HEPATOLOGY
- Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection
- (2016) Jordan J. Feld et al. LIVER INTERNATIONAL
- Chronic hepatitis C infection is associated with insulin resistance and lipid profiles
- (2015) Chia-Yen Dai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nutritional predictors of early mortality in incident hemodialysis patients
- (2013) Lilia R. Lukowsky et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Meta-analysis of observational studies: hepatitis C and survival after renal transplant
- (2013) F. Fabrizi et al. JOURNAL OF VIRAL HEPATITIS
- HCV Infection and the Incidence of CKD
- (2010) Adeel A. Butt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now